Posts by John

Zydus Lifesciences and Sunshine Holdings have launched a new joint venture to boost pharmaceutical access and medical supply chain efficiency in Sri Lanka.

A new clinical trial tests AI-run smart microcities to improve health outcomes for veterans and the homeless through predictive care and automated support.

Fosun Pharma is pivoting toward Alzheimer’s research, diversifying its global pipeline beyond oncology to target major breakthroughs in neurodegeneration.

New research shows lower plasminogen levels trigger faster liver repair. Discover the implications for post-surgical recovery and regenerative medicine.

A major medical journal retracts a study on cancer therapy timing due to data errors. Learn why rigorous evidence remains vital for oncology protocols.

The FDA has approved a breakthrough pediatric diabetes treatment. Discover how this new therapy is set to improve glycemic control and patient outcomes.

A new oral heart failure drug reports high safety and tolerability in a 58-patient clinical trial. Learn about this breakthrough in cardiac care.

Imagion Biosystems raises AU$3.75M to fund a Phase 2 clinical trial after receiving FDA clearance for its innovative cancer diagnostic technology.

Europe launches a €15M project to develop bacteriophage therapies as a powerful, targeted alternative to antibiotics in the fight against superbugs.

Servier has enrolled the first patient in a U.S. Phase Ib/II trial for a rare pediatric epilepsy syndrome, marking a key step in developing new treatments.